Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 13.57 is 31% above its 5-year average of 10.37, near the high end of its 5-year range (4.19–16.18).
As of the fiscal period ended Tuesday, June 30, 2026. 26.80% above its 12-month average of 10.70.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.57.
QUICK RATIO (ACID-TEST)
13.57
QUICK RATIO (ACID-TEST) AVG TTM
10.70
QUICK RATIO (ACID-TEST) AVG 3Y
9.23
QUICK RATIO (ACID-TEST) AVG 5Y
10.37
QUICK RATIO (ACID-TEST) AVG 10Y
7.41
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.80%
CURRENT VS 3Y AVG
+47.01%
CURRENT VS 5Y AVG
+30.94%
CURRENT VS 10Y AVG
+83.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+305.16%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.17B
Quick Ratio (Acid-Test)
13.57
TTM Avg
10.70
3Y Avg
9.23
5Y Avg
10.37
Market Cap
$5.17B
Quick Ratio (Acid-Test)
3.99
TTM Avg
2.37
3Y Avg
2.88
5Y Avg
3.42
Market Cap
$5.24B
Quick Ratio (Acid-Test)
2.53
TTM Avg
2.36
3Y Avg
1.93
5Y Avg
1.92
Market Cap
$5.27B
Quick Ratio (Acid-Test)
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$5.07B
Quick Ratio (Acid-Test)
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.06B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$5.03B
Quick Ratio (Acid-Test)
1.85
TTM Avg
1.98
3Y Avg
1.97
5Y Avg
1.88
Market Cap
$5.33B
Quick Ratio (Acid-Test)
3.28
TTM Avg
2.29
3Y Avg
2.05
5Y Avg
2.40
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.17B | 13.57 | 10.70 | 9.23 | 10.37 |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.17B | 3.99 | 2.37 | 2.88 | 3.42 |
| Sotera Health Company (SHC)vs › | $5.24B | 2.53 | 2.36 | 1.93 | 1.92 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.27B | 17.85 | 17.70 | 17.06 | 17.77 |
| Doximity, Inc. (DOCS)vs › | $5.28B | 6.08 | 6.53 | 6.56 | 6.07 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.07B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 2.79 | 2.90 | 2.74 | 2.21 |
| Waystar Holding Corp. (WAY)vs › | $5.03B | 1.85 | 1.98 | 1.97 | 1.88 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.33B | 3.28 | 2.29 | 2.05 | 2.40 |
| Erasca, Inc. (ERAS)vs › | $5.00B | 8.29 | 9.94 | 10.32 | 11.01 |
Quick Ratio
13.57
Excludes inventory
Current Ratio
13.57
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 13.57 |
| 2026-03-31 | 15.14 |
| 2025-12-31 | 14.23 |
| 2025-09-30 | 6.38 |
| 2025-06-30 | 4.19 |
| 2025-03-31 | 5.13 |
| 2024-12-31 | 5.32 |
| 2024-09-30 | 6.44 |
| 2024-06-30 | 9.25 |
| 2024-03-31 | 12.05 |
| 2023-12-31 | 7.09 |
| 2023-09-30 | 8.24 |
| 2023-06-30 | 12.99 |
| 2023-03-31 | 10.71 |
| 2022-12-31 | 9.87 |
| 2022-09-30 | 12.59 |
| 2022-06-30 | 11.96 |
| 2022-03-31 | 10.89 |
| 2021-12-31 | 13.04 |
| 2021-09-30 | 12.42 |
| 2021-06-30 | 16.18 |
| 2021-03-31 | 28.16 |
| 2020-12-31 | 18.70 |
| 2020-09-30 | 6.63 |
| 2020-06-30 | 2.90 |
| 2020-03-31 | 3.37 |
| 2019-12-31 | 3.06 |
| 2019-09-30 | 1.96 |
| 2019-06-30 | 2.41 |
| 2019-03-31 | 2.65 |
| 2018-12-31 | 3.25 |
| 2018-09-30 | 3.39 |
| 2018-06-30 | 3.91 |
| 2018-03-31 | 1.53 |
| 2017-12-31 | 3.78 |
| 2017-09-30 | 4.69 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-09-30 | 1.48 |
| 2015-09-30 | 0.00 |
